NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Drug cocktail shows promise for tough lung cancers
Disease control OngoingThis study tests a combination of three drugs (zimberelimab, domvanalimab, and etrumadenant) in 30 adults with advanced non-small cell lung cancer who have already tried immunotherapy. The goal is to see if the triple therapy can shrink tumors or slow cancer growth. Researchers a…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Personalized T-Cell army takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new treatment called T-Plex for people with advanced solid tumors that have not responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and attack multiple cancer-related targets. Th…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New combo therapy shows promise for tough lung cancer cases
Disease control OngoingThis study tests whether adding chemotherapy (carboplatin and pemetrexed) to the targeted drug osimertinib helps people with advanced non-small cell lung cancer that has both EGFR and TP53 gene mutations live longer without the cancer growing. About 294 adults who have not had pr…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Li Zhang, MD • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Blood test may take guesswork out of lung nodule decisions
Diagnosis OngoingThis study looks at whether a blood test called Nodify XL2 can help doctors better manage lung nodules that have a low to moderate chance of being cancer. About 2,000 adults over 40 with a solid lung nodule between 8 and 30 mm are taking part. The goal is to see if the test resul…
Matched conditions: NON-SMALL CELL CARCINOMA
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC